An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis

Andrea Necchi, Patrizia Giannatempo, Daniele Raggi, Luigi Mariani, Maurizio Colecchia, Elena Farè, Francesco Monopoli, Giuseppina Calareso, Siraj M. Ali, Jeffrey S. Ross, Jon H. Chung, Roberto Salvioni

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)201-203
Number of pages3
JournalEuropean Urology
Volume75
Issue number1
DOIs
Publication statusPublished - Jan 2019

ASJC Scopus subject areas

  • Urology

Cite this